Helius Medical Technologies (HSDT) – Company Press Releases
-
Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™
-
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
-
Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
-
Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke
-
Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference
-
Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller
-
Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients
-
Helius Booth and Special Event at APTA Combined Sections Meeting Will Highlight Physical Therapists’ Ability to Customize PoNS Therapy® to Improve Gait in People with MS
-
Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital
-
Helius Medical Technologies to Present at NobleCon19 Annual Conference
-
Helius Medical Technologies, Inc. Reports Third Quarter 2023 Financial Results
-
Helius Medical Technologies, Inc. Announces Study Results Demonstrating That PoNS Therapy™ Helps Patients with Traumatic Brain Injury Return to Work
-
Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024
-
Helius Medical Technologies, Inc. Receives Letter of Intent from the Québec Ministry of Health and Social Services to Purchase 30 PoNS® Devices
-
Helius Medical Technologies to Participate at Two Upcoming Healthcare Conferences
-
Helius Medical Technologies, Inc. Receives UPC Numbers for its PoNS® System and Mouthpiece
-
Helius to Bring its Innovative PoNS Therapy for Improvement of Gait in People with MS, to the 2023 Academy of Neurologic Physical Therapy Conference
-
University of Montreal’s School of Rehabilitation to Purchase Ten PoNS® Devices for Research Study on Stroke Recovery
-
Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference
-
Helius Medical Technologies, Inc. Compliant with All Applicable Nasdaq Listing Criteria
-
Helius Medical Technologies Announces Reverse Stock Split
-
Helius Medical Technologies, Inc. Reports Second Quarter 2023 Financial Results
-
Helius Medical Technologies, Inc. Announces Participation of Montefiore Medical Center in its PoNS® Therapeutic Experience Program
-
Helius Medical Technologies, Inc. to Release Second Quarter 2023 Financial Results on August 10, 2023
-
Helius Medical Technologies, Inc. Expands Stroke Trial at the Medical University of South Carolina
-
Helius Medical Technologies Announces DMEPOS Accreditation for PoNS
-
Helius Medical Technologies to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest
-
Helius Medical Technologies to Present at LD Micro Invitational XIII 2023
-
Helius to Highlight Innovative PoNS Therapy™ at the 2023 Consortium of Multiple Sclerosis Centers Annual Meeting, in Commemoration of World MS Day
-
Helius Medical Technologies, Inc. Reports First Quarter 2023 Financial Results
-
Helius Medical Technologies, Inc. to Release First Quarter 2023 Financial Results on May 11, 2023
-
Helius Medical Technologies to Spotlight Expanded Authorizations for its PoNS Device at 2023 American Academy of Neurology Annual Meeting, Booth 1685
-
Helius Medical Technologies to Spotlight Expanded Authorizations for its PoNS Device at 2023 American Academy of Neurology Annual Meeting, Booth 1685
-
Helius Medical Technologies, Inc. Announces Distribution of Series B Preferred Stock to Holders of its Class A Common Stock Intended to Facilitate a Reverse Stock Split, if Necessary
-
Helius Medical Technologies, Inc. Announces Distribution of Series B Preferred Stock to Holders of its Class A Common Stock Intended to Facilitate a Reverse Stock Split, if Necessary
-
Helius Medical Technologies and HealthTech Connex Announce Exclusive Distribution Agreement for the Portable Neuromodulation Stimulator (PoNS®) Device
-
Helius Medical Technologies and HealthTech Connex Announce Exclusive Distribution Agreement for the Portable Neuromodulation Stimulator (PoNS®) Device
-
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
-
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
-
Helius Medical Technologies Announces Authorization from Health Canada to Market Portable Neuromodulation Stimulator (PoNS®) Device for the Treatment of Gait Deficit Due to Mild and Moderate Symptoms
-
Helius Medical Technologies Announces Authorization from Health Canada to Market Portable Neuromodulation Stimulator (PoNS®) Device for the Treatment of Gait Deficit Due to Mild and Moderate Symptoms
-
Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023
-
Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023
-
Helius Medical Technologies to Present at the 35th Annual ROTH Conference
-
Helius Medical Technologies to Present at the 35th Annual ROTH Conference
-
Helius Medical Technologies to Showcase PoNS Therapy™ at American Physical Therapy Association’s 2023 Combined Sections Meeting
-
Helius Medical Technologies to Showcase PoNS Therapy™ at American Physical Therapy Association’s 2023 Combined Sections Meeting
-
Helius Medical Technologies, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2022
-
Helius Medical Technologies, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2022
-
Helius Medical Technologies to Present at the Virtual Q1 Investor Summit Microcap Event, January 26, 2023
Back to HSDT Stock Lookup
